Non-cirrhotic portal hypertension
Non-cirrhotic portal hypertension is a rare condition where blood pressure increases in the veins that carry blood to the liver, without the presence of cirrhosis or liver scarring. Unlike the more common form of portal hypertension caused by advanced liver disease, people with this condition often have relatively preserved liver function despite experiencing serious complications.
Table of contents
- What is non-cirrhotic portal hypertension?
- What causes this condition?
- Who is affected by non-cirrhotic portal hypertension?
- How does it present?
- How is it diagnosed?
- How is it treated?
- What is the outlook?
What is non-cirrhotic portal hypertension?
Non-cirrhotic portal hypertension refers to a group of conditions where there is increased blood pressure in the portal vein (the large vein that carries blood from the digestive organs to the liver) and related blood vessels, but without cirrhosis (scarring of the liver) or other typical causes of chronic liver disease.[1][2] This condition is also known as idiopathic non-cirrhotic portal hypertension (INCPH) or porto-sinusoidal vascular disorder (PSVD).[5]
The condition is classified based on where the blockage to blood flow occurs. It can be pre-hepatic (before the liver), hepatic (within the liver at different levels), or post-hepatic (after the liver).[1] In Western countries, the main causes of non-cirrhotic portal hypertension include porto-sinusoidal vascular disease and chronic portal vein thrombosis (blood clots in the portal vein).[1]
An important feature of this condition is that standard pressure measurement techniques used in cirrhosis may not detect the elevated pressure. The hepatic venous pressure gradient (HVPG), which is the gold standard test for measuring portal pressure in cirrhosis, can be normal in patients with non-cirrhotic portal hypertension because the blockage occurs before the liver sinusoids (tiny blood vessels in the liver).[3] This means a patient can have clear signs of portal hypertension, such as enlarged veins in the esophagus, yet have a normal HVPG reading.[3]
What causes this condition?
The exact cause of non-cirrhotic portal hypertension is often unknown, but several conditions have been associated with its development.[5][6] These associated conditions can be grouped into five main categories.
Immunological disorders are frequently linked to non-cirrhotic portal hypertension. These include conditions like common variable immunodeficiency syndrome, connective tissue diseases such as systemic lupus erythematosus, and inflammatory bowel disease like Crohn’s disease.[5]
Chronic infections can also contribute to the development of this condition. Worldwide, a parasitic infection called schistosomiasis is actually the most common cause of non-cirrhotic portal hypertension, particularly in developing countries.[11] HIV infection and its treatment have also been associated with the condition.[5]
Exposure to medications or toxins represents another category of risk factors. Certain drugs, including azathioprine, 6-thioguanine, didanosine, and exposure to substances like arsenic, have been linked to the development of non-cirrhotic portal hypertension.[5]
Genetic predisposition plays a role in some cases, with familial clustering reported and associations with genetic conditions like Adams-Oliver syndrome and Turner disease.[5]
Prothrombotic conditions (conditions that increase blood clotting) are commonly associated with non-cirrhotic portal hypertension. These include inherited blood clotting disorders, myeloproliferative diseases, and antiphospholipid syndrome.[5] Many patients with this condition develop portal vein thrombosis, with reported prevalence ranging from 13% to 46%.[6]
It is important to note that patients often have more than one of these risk factors present.[6]
Who is affected by non-cirrhotic portal hypertension?
Non-cirrhotic portal hypertension is considered a rare disease.[6] For years, it was thought to be extremely uncommon, but this was largely due to limited awareness and low suspicion among doctors.[1] The condition occurs worldwide but shows geographic variation in prevalence.
The disease is particularly prevalent in Asia, especially in India, Nepal, and Japan.[6] In Western countries, where the condition is less common, patients are typically diagnosed around age 40, with a predominance in males.[5] In India, the disease also shows male predominance but tends to appear at a younger age.[6] Conversely, in Japan, there appears to be a female predominance with onset typically in the fifth decade of life.[6]
Differences in socioeconomic status, living conditions, hygiene, pathogen exposure, and ethnicity may all play roles in the varying prevalence across different populations and countries.[5][6] Improvements in hygiene and living standards may explain the decreasing incidence reported in Japan in recent decades and the lower prevalence in Western countries.[5]
Patients with non-cirrhotic portal hypertension often differ from those with cirrhosis in that they tend to be younger and typically have preserved liver function even when portal hypertension is severe.[11]
How does it present?
Patients with non-cirrhotic portal hypertension usually present with signs and symptoms related to increased pressure in the portal vein system. Most commonly, around 70% of patients present with gastrointestinal bleeding from enlarged veins in the esophagus or stomach (varices).[11][5] Many patients have no symptoms until this bleeding occurs.[11]
Other common presentations include an enlarged spleen (splenomegaly), which may cause abdominal pain or a feeling of fullness, and low platelet count (thrombocytopenia).[5] Some patients develop ascites (fluid accumulation in the abdomen), which occurs in roughly 40% of cases.[11]
Less commonly, patients may experience hepatic encephalopathy (confusion due to liver problems), though this is mostly caused by large blood vessel bypasses rather than liver failure.[11] Portal vein thrombosis (blood clots in the portal vein) is a common complication that develops during the course of the disease.[5]
A key difference between non-cirrhotic portal hypertension and cirrhosis is that in the former, liver function remains relatively preserved. The liver can still perform most of its tasks despite the increased pressure in the blood vessels.[11] Patients may also have symptoms related to underlying associated conditions, such as immune disorders or infections.[5]
How is it diagnosed?
Diagnosing non-cirrhotic portal hypertension requires a high level of suspicion and is based on meeting specific criteria while excluding other causes of portal hypertension.[6] The formal diagnosis requires three elements: clear signs of portal hypertension, absence of cirrhosis or other causes of chronic liver disease, and absence of blood clots in the hepatic veins or portal vein on imaging studies.[5]
The diagnostic process typically begins with imaging studies. An abdominal ultrasound is often the first test performed. A skilled ultrasonographer may be able to distinguish features suggesting non-cirrhotic portal hypertension from cirrhosis, though this can be challenging. The ultrasound can show signs of portal hypertension and sometimes reveals thickening of the portal vein walls.[11]
A liver biopsy is mandatory to firmly establish the diagnosis and rule out cirrhosis or other causes of liver disease.[6][11] The biopsy may show a range of findings, from minor changes to features like sinusoidal dilatation, thickening and narrowing of small portal veins, portal fibrosis, and nodular regenerative hyperplasia.[5] However, these findings are not specific to this condition.
Liver stiffness measurement using technology like FibroScan can be helpful. Patients with non-cirrhotic portal hypertension typically have lower liver stiffness values (around 9 kPa on average) compared to patients with cirrhosis (over 14 kPa). If a patient has signs of portal hypertension with a FibroScan value below 12 kPa, non-cirrhotic portal hypertension should be considered.[11]
It is important to demonstrate that the major blood vessels (hepatic veins and portal vein) are open and not blocked by blood clots.[6] Additional testing should be performed to look for associated conditions such as immune disorders, infections, blood clotting disorders, and exposure to relevant medications or toxins.[5]
How is it treated?
Currently, there is no specific treatment aimed at changing the natural course of non-cirrhotic portal hypertension itself.[5] Treatment focuses on two main aspects: managing the underlying associated conditions and treating the complications of portal hypertension.[1]
The complications of portal hypertension in non-cirrhotic disease are managed similarly to those in cirrhosis, following current medical guidelines for cirrhotic portal hypertension.[1][5][6] For patients with enlarged esophageal or gastric veins, treatment includes medications called beta-blockers to reduce portal pressure and endoscopic procedures like band ligation to tie off the veins and prevent bleeding.[1]
For patients who develop complications that do not respond to standard treatments, more advanced procedures may be considered. TIPS (transjugular intrahepatic portosystemic shunt) is a procedure where a channel is created inside the liver to redirect blood flow and reduce portal pressure.[1] Research has shown that TIPS can be safe and effective in patients with non-cirrhotic portal hypertension, particularly those who have preserved kidney function and no severe other medical conditions.[13]
Liver transplantation may be considered for patients with progressive liver failure or complications that cannot be managed with other treatments.[1][5]
An important component of treatment is anticoagulation therapy (blood thinners). These medications are considered essential both for treating blood clots when they occur and for preventing recurrence of clots in the portal vein system.[1][6] Given the high risk of developing portal vein thrombosis in these patients, anticoagulation can be an important part of long-term management.
What is the outlook?
The prognosis for patients with non-cirrhotic portal hypertension is generally better than for those with cirrhosis-related portal hypertension. The survival and overall outlook are mainly limited by any underlying associated disorders rather than by liver failure itself.[5][6]
Because liver function is usually preserved, patients can tolerate complications better than those with cirrhosis.[11] The liver continues to function adequately despite the increased pressure in the portal vein system. However, some patients may develop liver-related complications that can affect their long-term prognosis and may eventually require liver transplantation.[6]
Doctors should be aware of the existence of non-cirrhotic portal hypertension and actively look for it in certain clinical settings, particularly in younger patients presenting with signs of portal hypertension but without obvious signs of advanced liver disease.[1] Early recognition is important for appropriate management and monitoring.
Large collaborative studies on the natural history of non-cirrhotic portal hypertension are still needed to better define optimal management strategies and improve long-term outcomes for patients with this condition.[1]
